Search Results - "Candel, M Gil"

4CPS-240 Fingolimod: analysis of use and safety in patients with relapsing-remitting multiple sclerosis by Ortiz Fernandez, P, Gil Candel, M, Martinez Soto, A, Herrero Fernandez, A, Fernandez-Villacañas Fernandez, P, Salar Valverde, I, Garcia Coronel, M, Pastor Mondéjar, C, Caballero Requejo, C, Urbieta Sanz, E

“…Background and ImportanceFingolimod is used when the disease remains active despite treatment with at least one other disease-modifying therapy, or is severe…”
Get full text

4CPS-326 Adalimumab’s persistence in rheumatological diseases by Pastor Mondéjar, C, Iniesta Navalón, C, Salar Valverde, I, Martínez Soto, AM, Ortiz Fernández, P, Gil Candel, M, Rentero Redondo, L, Onteniente Candela, M, García Coronel, M, Caballero Requejo, MDC, Urbieta Sanz, E

“…Background and importanceAdalimumab is a human monoclonal recombinant antibody whose mechanism of action is mediated by binding specifically to tumour necrosis…”
Get full text

5PSQ-179 Reason for discontinuation of biological drug treatment in rheumatoid arthritis by Pastor Mondéjar, C, Iniesta Navalón, C, Salar Valverde, I, Martínez Soto, AM, Ortíz Fernández, P, Gil Candel, M, García Coronel, M, Quesada Asencio, A, Onteniente Candela, M, Caballero Requejo, MDC, Urbieta Sanz, E

“…Background and importanceRheumatoid arthritis is a chronic, autoimmune disease, with unknown aetiology, characterised by chronic inflammation of synovial…”
Get full text

5PSQ-176 Discontinuation of etanercept due to adverse events in patients with rheumatic diseases by Pastor Mondéjar, C, Iniesta Navalón, C, Salar Valverde, I, Martínez Soto, AM, Ortíz Fernández, P, Gil Candel, M, Onteniente Candela, M, Quesada Asencio, A, Caballero Requejo, MDC, Rentero Redondo, L, Urbieta Sanz, E

“…Background and importanceEtanercept is a fusion protein composed of the p75 receptor of tumour necrosis factor (TNF) and the Fc portion of human…”
Get full text

5PSQ-022 Pharmacological cardioversion in patients with recent-onset atrial fibrillation at emergency department: efficacy and safety of vernakalant by Requejo, C Caballero, Candela, M Onteniente, Muñoz, C Gallego, Candel, M Gil, Valverde, I Salar, Sanz, E Urbieta, Salmerón, P Piñera

“…BackgroundAtrial fibrillation (AF) is one of the most common clinically significant cardiac arrhythmias. The management of AF includes conversion to sinus…”
Get full text

4CPS-234 Pharmaceutical interventions in the emergency department: relevance in high-alert medications by Requejo, C Caballero, Candela, M Onteniente, Ruiz, P Salmerón, Candel, M Gil, Valverde, I Salar, Muñoz, C Gallego, Sanz, E Urbieta

“…BackgroundThe Institute for Safe Medication Practices (ISMP) defines high-alert medications (HAM) as drugs that bear a heightened risk of causing significant…”
Get full text

5PSQ-083 Study of the prevalence of immunogenicity in patients treated with anti-tumour necrosis factor monoclonal antibodies by Candel, M Gil, Navalón, C Iniesta, Candela, M Onteniente, Redondo, L Rentero, Requejo, C Caballero, Valverde, N Salar, Muñoz, C Gallego

“…BackgroundThe loss of response in patients treated with anti-TNFα monoclonal antibodies is relatively frequent. One of the reasons is the development of…”
Get full text

5PSQ-033 High dosage of tigecycline in multidrug-resistant acinetobacter baumannii: use analysis during an outbreak by Requejo, C Caballero, Candel, M Gil, Muñoz, C Gallego, Candela, M Onteniente, Valverde, I Salar, Sanz, E Urbieta

“…BackgroundAcinetobacter baumannii has become an important hospital-acquired pathogen. With the rise in antibiotic resistance, tigecycline has been used…”
Get full text

4CPS-144 Effectiveness and safety of induction therapy with vedolizumab in patients with intestinal inflammatory disease by Muñoz, C Gallego, Candel, M Gil, Navalón, C Iniesta, Requejo, C Caballero, Candela, M Onteniente, Valverde, I Salar

“…BackgroundVedolizumab is a therapeutic alternative indicated in patients with moderate-severe inflammatory bowel disease (IBD) (ulcerative colitis (UC) and…”
Get full text

4CPS-222 Impact of the establishment of assisted electronic prescription on the improvement of the unit-dose drug dispensation system by Pastor Mondejar, C, Gil Candel, M, Salar Valverde, I, Onteniente Candela, M, Caballero Requejo, C, Iniesta Navalon, C, Urbieta Sanz, E

“…BackgroundThe aim of the unit-dose drug dispensation system (UDDDS) allows us to dispense the medication required for the patient for the following 24 hours…”
Get full text

3PC-051 Impact of ophthalmological preparations in the pharmacy service of a reference hospital by Salar Valverde, I, Manresa Ramon, N, Gil Candel, M, Onteniente Candela, M, Pastor Mondejar, C, Caballero Requejo, C, Iniesta Navalon, C, Garcia Coronel, M, Urbieta Sanz, E

“…BackgroundThere are many medicinal products that, although they have shown efficacy and safety in different ophthalmological indications, are not authorised or…”
Get full text

5PSQ-128 Pharmacotherapeutic profile and risk of drug-related problems and drug interactions in HIV+ patients of a health area by Onteniente Candela, M, Salar Valverde, I, Gil Candel, M, Pastor Mondéjar, C, Iniesta Navalón, C, Caballero Requejo, C, García Coronel, M, Urbieta Sanz, E

“…BackgroundThe expected lifespan of HIV +patients has increased dramatically as a result of improved antiretroviral therapy (ART), with the consequent increase…”
Get full text

4CPS-153 Comparative analysis between originator and biosimilar infliximab according to trough levels in patients with inflammatory bowel disease by Gil Candel, M, Iniesta Navalon, C, Onteniente Candela, M, Salar Valverde, N, Pastor Mondejar, C, Rentero Redondo, L, Caballero Requejo, C, Urbieta Sanz, E

“…BackgroundThe introduction of biosimilar infliximab (IFX-B) has led to a decrease in the costs of patients with inflammatory bowel disease (IBD). The molecular…”
Get full text

PS-075 Parametisation of a programme assisted electronic prescription in psychiatry by Candel, M Gil, Requejo, C Caballero, Sanz, E Urbieta, Sáez, C García-Molina, Candela, M Onteniente, Ruíz, A Trujillano

“…BackgroundIt has been demonstrated that assisted electronic prescription (AEP) is an effective measure of reducing medication errors. It is necessary to…”
Get full text

CP-133 Drug related problems in emergency department patients: role of clinical pharmacist by Requejo, C Caballero, Sáez, C García-Molina, Ruiz, A Trujillano, Candela, M Onteniente, Candel, M Gil, Sanz, E Urbieta, Salmerón, P Piñera

“…BackgroundDrug related problems (DRP) are relatively common in hospitalised patients and can result in patient morbidity and mortality. It has been shown that…”
Get full text

GM-030 Out of data sheet use of biological therapies in a reference hospital by Candela, M Onteniente, Ruiz, A Trujillano, Candel, M Gil, Requejo, C Caballero, Sáez, C García-Molina, Coronel, M García, Miguel, JJ Franco

“…BackgroundOff-label prescription is legal and common, but often not supported by strong evidence.PurposeTo analyse off-label treatments with biological…”
Get full text

CP-209 Metabolic complications in patients with parenteral nutrition by Candela, Onteniente, Vivancos, Ferriz, Navalón, C Iniesta, Candel, M Gil, Requejo, C Caballero, Ruiz, A Trujillano, Sáez, C García-Molina, Redondo, L Rentero

“…BackgroundParenteral nutrition (PN) is an important part of medical management of patients with a non-functioning and/or non-accessible gastrointestinal tract,…”
Get full text

CP-164 Adequacy of perioperative antibiotic prophylaxis and postoperative analgesia in a general surgery service by Candela, M Onteniente, Sanz, E Urbieta, Ruiz, A Trujillano, Requejo, C Caballero, Saéz, C García-Molina, Candel, M Gil

“…BackgroundProper prescription of perioperative antibiotic prophylaxis (PAP) and postoperative analgesia have been shown to decrease morbidity and mortality,…”
Get full text

PS-043 Medication reconciliation at hospital admission: Results evaluation and future prospects by Sáez, C García-Molina, Sanz, E Urbieta, Requejo, C Caballero, Ruiz, A Trujillano, Candela, M Onteniente, Candel, M Gil

“…BackgroundIn the past few years, many hospitals have implemented medication reconciliation procedures (MRP) at hospital admission as a strategy to enhance the…”
Get full text

PS-041 Drug dosing adjustments in patients with chronic kidney disease admitted to hospital through the emergency department by Sáez, C, Requejo, C Caballero, Ruiz, A, Urbieta Sanz, E, Onteniente Candela, M, Gil Candel, M

“…BackgroundChronic kidney disease (CKD) is an emerging problem worldwide due to the ageing population and increasing prevalence of risk factors, making it…”
Get full text